Articles

Unveiling the cancer epidemic in India: a glimpse into GLOBOCAN 2022 and past patterns

Singh K, Grover A, and Dhanasekaran K. The Lancet Regional Health – Southeast Asia 2025;34: 100546

..            The five most prevalent cancers affecting both genders collectively account for 44% of cancer burden in India. Notably, females exhibit higher crude incidence (104.5) and crude mortality (64.2) rates compared to males (91.5 and 62.2), based... Read More

23 Mar, 2026

Cancer Incidence and Mortality Across 43 Cancer Registries in India

National Cancer Registry Programme Investigator Group; Prashant Mathur, Krishnan Sathishkumar, Priyanka Das,et al. JAMA Netw Open 2025 Aug 1;8(8):e2527805

Cancer is a significant global health concern, with India ranking second in Asia and third in the world in terms of cancer incidence. Regular monitoring and updates on cancer statistics are vital for assessing the impact and burden of the disease and the effectiveness of cancer control measures. The incidence of 70... Read More

23 Mar, 2026

Burden of female-specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021

Wenhui Ren 1, Xiangyu Guo 2, Zheng Liu, et al. Cancer 2025 Jan 15;131(2):e35712

Breast cancer and reproductive system cancers remain significant public health threats for Chinese women. In 2021, China reported 385.84 thousand incident cases of female breast cancer, followed by cervical cancer, uterine cancer, and ovarian cancer. Breast cancer ranked as the primary cause of cancer-related deaths... Read More

23 Mar, 2026

Comparative analysis of cancer statistics in China and the United States in 2024Comparative analysis of cancer statistics in China and the United States in 2024

Yujie Wu, Siyi He, Mengdi Cao,et al. Chin Med J (Engl) 2024 Dec 20;137(24):3093-3100

https://doi.org/10.1016/j.jncc.2024.06.005 In 2024, there are an estimated 3,246,625 and 2,510,597 new cancer cases and 1,699,066 and 640,038 cancer deaths in China and the US, respectively. The highest estimated cancer cases are lung cancer in China and breast cancer in the US. The age-standardized incidence ra... Read More

23 Mar, 2026

Cancer survival statistics in China 2019-2021: a multicenter, population-based study

Hongmei Zeng, Rongshou Zheng, Kexin Sun et al. J Natl Cancer Cent. 2024 Jun 22;4(3):203-213

A milestone goal of the Healthy China Program (2019-2030) is to achieve 5-year cancer survival at 43.3% for all cancers combined by 2022. To assess the progress towards this target, we analyzed the updated survival for all cancers combined and 25 specific cancer types in China from 2019 to 2021.  In 2019-2021,... Read More

23 Mar, 2026

Cancer incidence and mortality in China, 2022

Bingfeng Han 1, Rongshou Zheng 1, Hongmei Zeng 1, et al. J Natl Cancer Cent. 2024 Feb 2;4(1):47-53

The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of countries around the world every two years. NCC has received approval from the Nation... Read More

23 Mar, 2026

Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis

Edward Christopher Dee, Mathieu Laversanne, Nirmala Bhoo-Pathy Lancet Oncol. 2025 Apr;26(4):516-528

Cancer is a leading cause of morbidity and mortality in southeast Asia. We aimed to present and interpret cancer incidence and mortality statistics in the 11 constituent countries of Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Timor-Leste, and Viet Nam to inform research ... Read More

23 Mar, 2026

Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Breast Cancer. The Lancet Oncology. 2026. 27:302-326

In 2023, there were an estimated 2·30 million breast cancer incident cases, 764 000 deaths , and 24·1 million DALYs among females globally. The age-standardised incidence rate (ASIR) was the highest (24·1 per 100 000 [16·8 to 31·9]). The highest ASIR was in the high-income group and the lowest ASMR was in the upper... Read More

23 Mar, 2026

Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040

Youao Zhang, Pinhao Wang, Zixuan Jia,et al. Sci Rep. 2025 Feb 11;15(1):5123

Male cancers, which refers to cancers that occur exclusively in males, is a prevalent type of cancer worldwide, primarily including prostate cancer (PCa) and testicular cancer (TCa). These cancers are significant contributors to the global disease burden. We analyzed Global Burden of Disease (GBD) 2021 on male canc... Read More

23 Mar, 2026

Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates

Habtamu Mellie Bizuayehu, Abel F Dadi, Kedir Y Ahmed Cancer 2024 Nov 1;130(21):3708-3723

Men exhibit higher prevalence of modifiable risk factors, such as smoking and alcohol consumption, leading to greater cancer incidence and lower survival rates. The authors analyzed 30 cancer types among men in 2022, with projections estimated for 2050. In 2022, a high MIR (indicating poor survival) was observed am... Read More

23 Mar, 2026